Primary Job Title Chief Operating Officer Primary Organization CatSci
Location United Kingdom, Europe Regions Europe, Middle East, and Africa (EMEA) Gender Male Also Known As Simon N. G. Tyler
Website catsci.com/who-we-are/dr-simon-n-g-tyler/ LinkedIn View on LinkedIn
Simon obtained an MA in Natural Sciences (Chemistry) from Hertford College, Oxford in 1995 and earned a PhD in 1998 after research on asymmetric synthesis in the group of Prof. Laurence M. Harwood. Then followed a two-year post-doctoral stint with Prof. Barry M. Trost at Stanford University, studying the catalysis of the Claisen rearrangement. In
2001, Simon returned to the UK to join Process R&D in AstraZeneca, gaining experience and understanding of the multi-disciplinary needs of drug development to lead significant process development projects ranging from candidate selection to Phase III, therein establishing a record of exploiting innovative synthetic and catalytic chemistry for the manufacture of drug candidates. After ten years in big pharma, Simon played a pivotal role as a co-founder of CatSci Ltd, negotiating the financial terms for the asset transfer and service agreement with AstraZeneca. After an initial operational role during the establishment of the new start-up, he subsequently took on commercial responsibility for the company, overseeing growth to a multi-million pound business. He currently serves as Chief Operating Officer, focused on unleashing the talents of staff across the organisation to exceed the expectations of customers. As a dynamic leader, he is committed to the development of others through vision, participation and affiliation.
